| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetics, Medical | 8 | 2021 | 51 | 2.120 |
Why?
|
| Genetic Testing | 10 | 2018 | 543 | 1.260 |
Why?
|
| Chromosome Deletion | 9 | 2015 | 227 | 1.200 |
Why?
|
| Intellectual Disability | 7 | 2018 | 188 | 1.140 |
Why?
|
| Chromosome Disorders | 5 | 2015 | 113 | 1.050 |
Why?
|
| Developmental Disabilities | 7 | 2016 | 200 | 1.010 |
Why?
|
| Neonatal Screening | 5 | 2017 | 65 | 0.970 |
Why?
|
| Education, Medical | 2 | 2020 | 243 | 0.920 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2017 | 8 | 0.920 |
Why?
|
| Internet | 3 | 2014 | 323 | 0.880 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 234 | 0.850 |
Why?
|
| Genomics | 6 | 2021 | 778 | 0.830 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2020 | 182 | 0.800 |
Why?
|
| Genetic Counseling | 4 | 2016 | 102 | 0.760 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 64 | 0.690 |
Why?
|
| Mosaicism | 3 | 2017 | 71 | 0.670 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 46 | 0.590 |
Why?
|
| Mutation | 15 | 2018 | 4169 | 0.540 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2016 | 8 | 0.520 |
Why?
|
| Seizures | 2 | 2015 | 307 | 0.500 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 39 | 0.480 |
Why?
|
| Infant, Newborn | 15 | 2017 | 2497 | 0.470 |
Why?
|
| Information Services | 1 | 2014 | 23 | 0.450 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 41 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2010 | 125 | 0.430 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2011 | 101 | 0.430 |
Why?
|
| Disclosure | 1 | 2014 | 109 | 0.430 |
Why?
|
| Gene Frequency | 4 | 2015 | 687 | 0.430 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 115 | 0.430 |
Why?
|
| Child, Preschool | 15 | 2018 | 3773 | 0.420 |
Why?
|
| Humans | 60 | 2021 | 89985 | 0.410 |
Why?
|
| Chromosomes, Human, Y | 2 | 2017 | 24 | 0.400 |
Why?
|
| Internship and Residency | 1 | 2021 | 1063 | 0.400 |
Why?
|
| Consensus | 1 | 2014 | 366 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2011 | 59 | 0.390 |
Why?
|
| Nuclear Proteins | 5 | 2018 | 728 | 0.380 |
Why?
|
| Infant | 15 | 2018 | 3189 | 0.380 |
Why?
|
| Growth Disorders | 3 | 2005 | 63 | 0.370 |
Why?
|
| Copper | 3 | 2000 | 78 | 0.370 |
Why?
|
| Chondrodysplasia Punctata | 2 | 2009 | 6 | 0.370 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 19 | 0.370 |
Why?
|
| Epilepsy | 1 | 2015 | 424 | 0.360 |
Why?
|
| Facies | 3 | 2013 | 27 | 0.350 |
Why?
|
| Membrane Proteins | 2 | 2016 | 1227 | 0.330 |
Why?
|
| Precision Medicine | 1 | 2014 | 413 | 0.330 |
Why?
|
| Vitamin K Deficiency | 1 | 2009 | 5 | 0.330 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.330 |
Why?
|
| Educational Measurement | 2 | 2021 | 231 | 0.320 |
Why?
|
| Chromosome Mapping | 4 | 2013 | 1074 | 0.320 |
Why?
|
| Databases, Genetic | 2 | 2009 | 269 | 0.310 |
Why?
|
| Ataxia | 3 | 2018 | 40 | 0.310 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 1243 | 0.300 |
Why?
|
| Gene Duplication | 2 | 2012 | 129 | 0.290 |
Why?
|
| Fetal Growth Retardation | 1 | 2008 | 68 | 0.290 |
Why?
|
| DiGeorge Syndrome | 1 | 2007 | 14 | 0.280 |
Why?
|
| Child | 16 | 2018 | 7242 | 0.280 |
Why?
|
| Hand Deformities, Congenital | 3 | 2005 | 15 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2005 | 387 | 0.280 |
Why?
|
| Fathers | 1 | 2008 | 72 | 0.280 |
Why?
|
| Female | 36 | 2018 | 46602 | 0.270 |
Why?
|
| Genetic Linkage | 1 | 2008 | 624 | 0.270 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 200 | 0.270 |
Why?
|
| Syndrome | 9 | 2013 | 450 | 0.270 |
Why?
|
| Karyotyping | 3 | 2018 | 252 | 0.260 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 344 | 0.260 |
Why?
|
| Cation Transport Proteins | 2 | 2012 | 67 | 0.260 |
Why?
|
| Pyloric Stenosis | 1 | 2005 | 8 | 0.250 |
Why?
|
| Male | 30 | 2018 | 42690 | 0.250 |
Why?
|
| Phenotype | 11 | 2018 | 2457 | 0.250 |
Why?
|
| Clinical Competence | 2 | 2021 | 797 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2015 | 47 | 0.230 |
Why?
|
| Genome, Human | 3 | 2016 | 791 | 0.230 |
Why?
|
| Exome | 4 | 2018 | 131 | 0.230 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 521 | 0.220 |
Why?
|
| Genes, Recessive | 2 | 2015 | 86 | 0.220 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2003 | 5 | 0.220 |
Why?
|
| Ophthalmoplegia | 1 | 2003 | 11 | 0.220 |
Why?
|
| Chromosome Aberrations | 2 | 2018 | 384 | 0.220 |
Why?
|
| Pedigree | 8 | 2015 | 969 | 0.220 |
Why?
|
| Prions | 2 | 2000 | 54 | 0.210 |
Why?
|
| Computational Biology | 1 | 2006 | 551 | 0.210 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2008 | 352 | 0.200 |
Why?
|
| Superoxide Dismutase | 2 | 2000 | 177 | 0.200 |
Why?
|
| Curriculum | 3 | 2020 | 573 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 2360 | 0.190 |
Why?
|
| Certification | 1 | 2021 | 61 | 0.190 |
Why?
|
| Students, Medical | 1 | 2006 | 425 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2002 | 47 | 0.180 |
Why?
|
| Foot Deformities, Congenital | 1 | 2000 | 10 | 0.180 |
Why?
|
| Microarray Analysis | 2 | 2018 | 95 | 0.180 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2000 | 10 | 0.180 |
Why?
|
| Licensure, Medical | 1 | 2020 | 20 | 0.180 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2000 | 12 | 0.180 |
Why?
|
| Duodenal Diseases | 1 | 2000 | 23 | 0.180 |
Why?
|
| Electron Transport Complex IV | 1 | 2000 | 49 | 0.170 |
Why?
|
| Neurofibromatosis 1 | 1 | 2000 | 39 | 0.170 |
Why?
|
| Microcephaly | 1 | 2000 | 77 | 0.170 |
Why?
|
| Monosomy | 1 | 1999 | 12 | 0.170 |
Why?
|
| United States | 3 | 2021 | 7114 | 0.170 |
Why?
|
| Craniofacial Dysostosis | 1 | 1999 | 12 | 0.160 |
Why?
|
| Sequence Deletion | 2 | 2013 | 205 | 0.160 |
Why?
|
| Methylmalonic Acid | 1 | 1998 | 6 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 1999 | 51 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1999 | 100 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2000 | 271 | 0.160 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2018 | 14 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 563 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2018 | 32 | 0.150 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 28 | 0.150 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2017 | 8 | 0.150 |
Why?
|
| Phytosterols | 1 | 2017 | 6 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2018 | 78 | 0.150 |
Why?
|
| Chromosomes | 1 | 2018 | 98 | 0.150 |
Why?
|
| Ezetimibe | 1 | 2017 | 35 | 0.150 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 2012 | 6 | 0.150 |
Why?
|
| Rare Diseases | 1 | 2017 | 69 | 0.140 |
Why?
|
| Face | 1 | 2018 | 118 | 0.140 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2017 | 4 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 79 | 0.140 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 159 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 2 | 2012 | 155 | 0.140 |
Why?
|
| Founder Effect | 2 | 2014 | 104 | 0.140 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 141 | 0.130 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 17 | 0.130 |
Why?
|
| Dental Enamel | 1 | 2016 | 16 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2016 | 281 | 0.130 |
Why?
|
| Estradiol | 1 | 2017 | 250 | 0.130 |
Why?
|
| Thiolester Hydrolases | 1 | 2016 | 14 | 0.130 |
Why?
|
| Adult | 11 | 2018 | 26827 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 49 | 0.130 |
Why?
|
| Fanconi Anemia | 1 | 2015 | 9 | 0.130 |
Why?
|
| Adolescent | 10 | 2018 | 9345 | 0.130 |
Why?
|
| Testosterone | 1 | 2017 | 272 | 0.120 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2015 | 4 | 0.120 |
Why?
|
| Genes, Lethal | 1 | 2015 | 53 | 0.120 |
Why?
|
| Illinois | 2 | 2017 | 485 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2010 | 365 | 0.120 |
Why?
|
| Trisomy | 2 | 2013 | 54 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 538 | 0.120 |
Why?
|
| Brain | 3 | 2015 | 2306 | 0.120 |
Why?
|
| Genetic Research | 1 | 2014 | 18 | 0.120 |
Why?
|
| Genetic Carrier Screening | 1 | 2014 | 59 | 0.110 |
Why?
|
| Temporal Lobe | 1 | 2015 | 176 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 490 | 0.110 |
Why?
|
| Prenatal Diagnosis | 2 | 2012 | 110 | 0.110 |
Why?
|
| Desmocollins | 1 | 2013 | 3 | 0.110 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2013 | 10 | 0.110 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2013 | 15 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2013 | 63 | 0.110 |
Why?
|
| Movement Disorders | 1 | 2013 | 44 | 0.110 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 23 | 0.110 |
Why?
|
| Telomere | 2 | 2005 | 119 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.110 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2012 | 3 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2013 | 64 | 0.110 |
Why?
|
| Failure to Thrive | 1 | 2012 | 17 | 0.100 |
Why?
|
| Consanguinity | 2 | 2013 | 73 | 0.100 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2012 | 3 | 0.100 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2012 | 7 | 0.100 |
Why?
|
| New York | 1 | 2012 | 73 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2013 | 77 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 160 | 0.100 |
Why?
|
| Hippocampus | 1 | 2015 | 449 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2014 | 872 | 0.090 |
Why?
|
| Synaptic Membranes | 1 | 2011 | 14 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 365 | 0.090 |
Why?
|
| X Chromosome Inactivation | 2 | 2009 | 28 | 0.090 |
Why?
|
| Mass Screening | 1 | 2015 | 647 | 0.090 |
Why?
|
| Turner Syndrome | 1 | 2010 | 27 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2009 | 296 | 0.090 |
Why?
|
| Oxidoreductases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 148 | 0.090 |
Why?
|
| Haplotypes | 2 | 2012 | 637 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2005 | 163 | 0.090 |
Why?
|
| Physicians | 2 | 2015 | 692 | 0.090 |
Why?
|
| De Lange Syndrome | 1 | 2009 | 10 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2005 | 528 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 35 | 0.080 |
Why?
|
| Consumer Advocacy | 1 | 2009 | 10 | 0.080 |
Why?
|
| Pregnancy, High-Risk | 1 | 2009 | 16 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2009 | 27 | 0.080 |
Why?
|
| Parents | 1 | 2012 | 290 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 60 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 72 | 0.080 |
Why?
|
| Young Adult | 6 | 2018 | 6415 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2009 | 50 | 0.080 |
Why?
|
| Microphthalmos | 1 | 2008 | 7 | 0.080 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 11 | 0.080 |
Why?
|
| Limb Deformities, Congenital | 1 | 2008 | 20 | 0.080 |
Why?
|
| Genotype | 5 | 2017 | 1852 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 432 | 0.080 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2008 | 11 | 0.080 |
Why?
|
| Lod Score | 1 | 2008 | 152 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 313 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2005 | 109 | 0.080 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 71 | 0.070 |
Why?
|
| Pregnancy | 4 | 2012 | 3046 | 0.070 |
Why?
|
| Canada | 2 | 2018 | 208 | 0.070 |
Why?
|
| Radiography | 2 | 2000 | 808 | 0.070 |
Why?
|
| Dystrophin | 1 | 2007 | 22 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 32 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 869 | 0.070 |
Why?
|
| Diseases in Twins | 1 | 2007 | 65 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2005 | 340 | 0.070 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 55 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 399 | 0.070 |
Why?
|
| Copper-transporting ATPases | 2 | 2012 | 12 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 2064 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 78 | 0.070 |
Why?
|
| Homozygote | 3 | 2013 | 200 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 178 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2005 | 2886 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 241 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 3024 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2005 | 418 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 235 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2017 | 8277 | 0.060 |
Why?
|
| Proteins | 2 | 2009 | 787 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2006 | 136 | 0.060 |
Why?
|
| Genes, Dominant | 2 | 2005 | 117 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 26159 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 126 | 0.060 |
Why?
|
| Animals | 7 | 2010 | 27536 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1145 | 0.050 |
Why?
|
| Models, Biological | 2 | 2007 | 1766 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2009 | 679 | 0.050 |
Why?
|
| Risk Factors | 2 | 2017 | 5562 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2000 | 188 | 0.050 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2000 | 9 | 0.050 |
Why?
|
| PrPC Proteins | 1 | 2000 | 13 | 0.040 |
Why?
|
| PrPSc Proteins | 1 | 2000 | 22 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2000 | 66 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 94 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2000 | 48 | 0.040 |
Why?
|
| Family Health | 1 | 2000 | 162 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 1999 | 17 | 0.040 |
Why?
|
| Sex Differentiation | 1 | 1999 | 9 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 1999 | 8 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2000 | 138 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 120 | 0.040 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1999 | 19 | 0.040 |
Why?
|
| Spine | 1 | 2000 | 102 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2000 | 131 | 0.040 |
Why?
|
| Prion Diseases | 1 | 1999 | 35 | 0.040 |
Why?
|
| Euchromatin | 1 | 1999 | 6 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 288 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1998 | 11 | 0.040 |
Why?
|
| Propionates | 1 | 1998 | 33 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 1998 | 24 | 0.040 |
Why?
|
| Arm | 1 | 1999 | 99 | 0.040 |
Why?
|
| Sitosterols | 1 | 2017 | 3 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 34 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 1999 | 213 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 36 | 0.040 |
Why?
|
| Exons | 2 | 2012 | 453 | 0.040 |
Why?
|
| Puberty | 1 | 2017 | 60 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 45 | 0.040 |
Why?
|
| Dried Blood Spot Testing | 1 | 2017 | 10 | 0.040 |
Why?
|
| Genetics | 1 | 2017 | 24 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 1999 | 146 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 104 | 0.030 |
Why?
|
| Heart Diseases | 1 | 1999 | 302 | 0.030 |
Why?
|
| Testis | 1 | 2017 | 152 | 0.030 |
Why?
|
| Alleles | 2 | 2013 | 1137 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 1579 | 0.030 |
Why?
|
| Chromatin | 1 | 1999 | 404 | 0.030 |
Why?
|
| Cholesterol | 1 | 2017 | 360 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1179 | 0.030 |
Why?
|
| Mice | 2 | 2000 | 11858 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 262 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 418 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 2015 | 34 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 9216 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 1999 | 515 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6785 | 0.030 |
Why?
|
| Calibration | 2 | 2005 | 103 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1250 | 0.030 |
Why?
|
| Syria | 1 | 2013 | 2 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 73 | 0.030 |
Why?
|
| Pierre Robin Syndrome | 1 | 2013 | 13 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 2013 | 52 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2013 | 26 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 39 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 58 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 2005 | 58 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 101 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 85 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1880 | 0.030 |
Why?
|
| North America | 1 | 2013 | 188 | 0.030 |
Why?
|
| Endocardium | 1 | 2013 | 98 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1604 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 96 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 116 | 0.030 |
Why?
|
| Lysosomes | 1 | 2013 | 113 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2013 | 210 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2000 | 1665 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2013 | 515 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2012 | 98 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2009 | 720 | 0.020 |
Why?
|
| Serum Amyloid A Protein | 1 | 1991 | 25 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 423 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 255 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 373 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Pediatrics | 1 | 2015 | 361 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 646 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1778 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 1991 | 192 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2010 | 73 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 223 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 19 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 948 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2000 | 3404 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1492 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 247 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 264 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 92 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1309 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5358 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 295 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 55 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 19262 | 0.020 |
Why?
|
| Head | 1 | 2008 | 136 | 0.020 |
Why?
|
| Zebrafish | 1 | 2010 | 322 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 137 | 0.020 |
Why?
|
| Pentosyltransferases | 1 | 2007 | 35 | 0.020 |
Why?
|
| Prognosis | 2 | 2005 | 3800 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 30 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2009 | 2026 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 64 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 578 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1075 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2005 | 9 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2005 | 51 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1158 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 543 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 79 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 108 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2002 | 135 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2329 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 824 | 0.010 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2000 | 14 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2000 | 15 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2018 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2002 | 299 | 0.010 |
Why?
|
| Liver | 2 | 1998 | 1211 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 144 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2000 | 277 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 309 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 391 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 909 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 1130 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 1534 | 0.010 |
Why?
|
| Fingers | 1 | 1998 | 69 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 759 | 0.010 |
Why?
|
| Calcinosis | 1 | 1998 | 230 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 2495 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 4048 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 1991 | 16 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1991 | 72 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1991 | 105 | 0.010 |
Why?
|
| Cricetinae | 1 | 1991 | 558 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 295 | 0.010 |
Why?
|
| Cytokines | 1 | 1991 | 811 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 1983 | 0.000 |
Why?
|